Literature DB >> 7306006

The binding of [3H]adenosine to synaptosomal and other preparations from the mammalian brain.

M E Newman, J Patel, H McIlwain.   

Abstract

1. A high-affinity adenosine-binding site with Kd(adenosine) 0.5-1.3 microM was demonstrated in particulate and synaptosomal fractions isolated from the cerebral cortex of guinea pig, rat and ox. 2. Binding of [3H]adenosine to this site was inhibited by theophylline and by 2-chloroadenosine, but not by four other adenosine analogues. 3. Endogenous adenosine, found to be present in some preparations at approx. 1 pmol/mg of protein, diminished the binding capacity of the preparations for [3H]adenosine. 4. Addition of the adenosine deaminase inhibitor erythro-9-[1-(1-hydroxyethyl)heptyl]-adenine revealed the presence of a second lower affinity binding site with Kd (adenosine) 5-9 microM and a higher maximal adenosine-binding capacity. The inhibitor partially blocked binding to the high-affinity site in preparations from which adenosine deaminase had been removed by washing. 5. To preparations of particulate fractions maintained under iso-osmotic conditions, adenosine attachment was non-saturable and temperature-dependent, indicating the existence of an active uptake process. 6. The location and binding constant of the high-affinity adenosine-binding site suggest that it corresponds to the receptor site for adenosine-activated adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7306006      PMCID: PMC1162786          DOI: 10.1042/bj1940611

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  22 in total

1.  Cellular site and state combination of the adenosine 3':5'-cyclic monophosphate persisting after excitation of cerebral tissues.

Authors:  M Newman; H McIlwain
Journal:  Biochem J       Date:  1978-01-15       Impact factor: 3.857

2.  Adenosine-sensitive adenylate cyclase in rat striatal homogenates and its relationship to dopamine- and Ca2+-sensitive adenylate cyclases.

Authors:  J Prémont; M Perez; J Bockaert
Journal:  Mol Pharmacol       Date:  1977-07       Impact factor: 4.436

3.  Two distinct adenosine-sensitive sites on adenylate cyclase.

Authors:  C Londos; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

4.  The effect of adenosine and adenine nucleotides on the cyclic adenosine 3', 5'-phosphate content of guinea pig cerebral cortex slices.

Authors:  A Sattin; T W Rall
Journal:  Mol Pharmacol       Date:  1970-01       Impact factor: 4.436

5.  The effect of electrical stimulation upon the accumulation of adenosine 3',5'-phosphate in isolated cerebral tissue.

Authors:  S Kakiuchi; T W Rall; H McIlwain
Journal:  J Neurochem       Date:  1969-04       Impact factor: 5.372

6.  Purine salvage at the cholinergic nerve endings of the Torpedo electric organ: the central role of adenosine.

Authors:  H Zimmermann; M J Dowdall; D A Lane
Journal:  Neuroscience       Date:  1979       Impact factor: 3.590

7.  Characterization of [3H]adenosine binding to fat cell membranes.

Authors:  C C Malbon; R C Hert; J N Fain
Journal:  J Biol Chem       Date:  1978-05-10       Impact factor: 5.157

Review 8.  Regulatory significance of the release and action of adenine derivatives in cerebral systems.

Authors:  H McIlwain
Journal:  Biochem Soc Symp       Date:  1972

9.  Rat cerebral-cortex adenosine deaminase activity and its subcellular distribution.

Authors:  I Pull; H McIlwain
Journal:  Biochem J       Date:  1974-10       Impact factor: 3.857

10.  Adenosine as a constituent of the brain and of isolated cerebral tissues, and its relationship to the generation of adenosine 3':5'-cyclic monophosphate.

Authors:  M Newman; H McIlwain
Journal:  Biochem J       Date:  1977-04-15       Impact factor: 3.857

View more
  1 in total

1.  Cyclic AMP-binding capacities and histone kinase activation in subcellular components of neocortical tissue. Differential responses to three neurohumoural agents.

Authors:  J Patel; M Newman; H McIlwain
Journal:  Biochem J       Date:  1981-02-15       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.